Cite Filings / CPIX / 0001104659-25-104396

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2025-10-30 Acc 0001104659-25-104396

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-04 8-K Results of operations
2025-11-03 4 Director acquired 1,564 shares (code L)
2025-11-03 4 Director acquired 138 shares (code L)
2025-11-03 4 Director acquired 299 shares (code L)
2025-11-03 4 Chairman and CEO acquired 299 shares (code L)
2025-10-30 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-04-24 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…